The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Aripiprazole 15 mg tablets

15 milligram(s) Tablet

Brillpharma (Ireland) LimitedPA22749/016/003

Main Information

Trade NameAripiprazole 15 mg tablets
Active SubstancesAripiprazole
Strength15 milligram(s)
Dosage FormTablet
Licence HolderBrillpharma (Ireland) Limited
Licence NumberPA22749/016/003

Group Information

ATC CodeN05AX Other antipsychotics
N05AX12 aripiprazole

Status

Authorised/WithdrawnAuthorised
Licence Issued06/10/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0092-032-056
Interchangeable List DocumentPDF of Interchangeable List
« Back